Kim Kardashian Instagram post promoting drug slapped with FDA complaint
Few would dare criticize a Kim Kardashian Instagram post and expect to not attract a flock of haters—the U.S. government faces no such risk.
Which is why on Aug. 7, the Food and Drug Administration issued a complaint to Duchesnay, the maker of a morning-sickness drug, for having the reality TV star promote their product on her social media accounts (she also did a Facebook post), without stating any of the drug’s risks.
In the Instagram post, Kardashian, who is pregnant, said Diclegis, had made her “feel a lot better” and added that, “It’s been studied and there was no increased risk to the baby.”
The problem is, according to the nearly 400-word warning on Duchesnay’s website, the drug does have other side effects, like drowsiness, and has not been tested on women with hyperemesis gravidarum, which Kate Middleton went through during her first pregnancy.